It feels like the market just now found out that we’re having a good earnings season. It took solid reports from the likes of Caterpillar and McDonalds, among others, to force the realization, but better late than never. As a result, stocks followed up yesterday’s sharp rally with an encore. The NASDAQ won the headlines on Tuesday with a gain of 0.70% to 6025.5, marking its first close over 6,000. The Dow looked like it would reclaim 21,000, but ended just short with an advance of 1.12% to 20,996.1. The S&P was up 0.61% to 2388.6. In addition to the earnings reports, the market is also quite excited about seeing some particulars of President Trump’s tax plan tomorrow…though whether or not it can get passed is another matter. The portfolios continue to be active, and now there’s a new member. Our latest service Healthcare Innovators has been launched, and it added its first six picks this morning. Read the highlights section below to learn more about these inaugural buys, along with other moves by TAZR Trader, Surprise Trader, Momentum Trader, Stocks Under $10 and Short List: Today's Portfolio Highlights: Healthcare Innovators: The brand new Healthcare Innovators portfolio launched today and bought its first 6 positions. Eventually, this equal-weighted, long-term service will have 20 to 25 stocks. Kevin’s inaugural picks are Gilead Sciences (GILD), Celgene (CELG), Edwards Lifesciences (EW), BioTelemetry (BEAT), Alexion Pharmaceuticals (ALXN) and Juno Therapeutics (JUNO). Get specifics on each of these stocks in the full write-up. And make sure to read this new portfolio’s Guide, where you’ll learn Kevin's methodology and the four megatrend drivers that should keep healthcare a hot space for years to come. TAZR Trader: The portfolio had a double-digit profit yesterday after selling a stock to cash in on heavy tech exposure and to protect from political uncertainty in the upcoming budget battle. Kevin used the exact same criteria today…and got TWO big winners! He sold half of Lam Research (LRCX) for a 14% return and half of Facebook (FB) for a 12% gain. Surprise Trader: The portfolio swapped out two names on Tuesday by selling LMT and DHI before buying Cooper Tire & Rubber (CTB) and Lear Corp. (LEA). The new stocks are both Zacks Rank #2s with VGM Scores of A and double digit average surprises over the past four quarters. CTB has a “stunning” Earnings ESP of 14.5% for the quarter being reported before the bell on Thursday and is in the top 10% of the Zacks Industry Rank. LEA has an Earnings ESP of 4.05% for the quarter being reported before the bell tomorrow and is in the top 25% of the Zacks Industry Rank. Read the complete commentary for more on today’s moves. Momentum Trader: Commercial Vehicle Group (CVGI) is a stock on the move, which is apropos since it’s in the trucking, construction and specialty transportation business. It’s part of a top industry and is a Zacks Rank #1. Dave thinks this approximately $9 stock will be in the double digits soon, so he decided to chase the breakout. The editor got out of the choppy PCH position and shifted the money into a 12.5% allocation in CVGI. The full write-up has a lot more on this new addition, including a breakdown of its chart. Stocks Under $10: It’s going to start getting hot outside before you know it, so Brian Bolan thought it was a good time to add commercial air conditioning company Hudson Technologies (HDSN) to the portfolio. The editor is expecting good things for the company’s next report on May 3. Last time, HDSN met on the bottom line and beat on top. Read the complete commentary for a lot more on this latest addition, including its earnings estimates, valuation and the limit that Brian wants to use. Zacks Short List: Nearly half of the portfolio was swapped out this week. The service short-covered Anadarko Petroleum (APC, +4%), WMB, INCY and PTC. The new additions replacing these names are Terex Corp. (TEX), Snyders Lance (LNCE), Newmont Mining (NEM) and Wynn Resorts (WYNN). Learn more about this emotion-free portfolio that takes advantage of falling and volatile markets by reading the Short List Trader Guide. Have a Great Evening, Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >> Zacks Investment Research